ATE207120T1 - Dna-sequenzen des epstein-barr virus kodierend für ein diagnostisch relevantes virus-hüllprotein,durch pcr erhaltene expressionsklone und verwendung dieses rekombinanten antigens in diagnostischen tests - Google Patents

Dna-sequenzen des epstein-barr virus kodierend für ein diagnostisch relevantes virus-hüllprotein,durch pcr erhaltene expressionsklone und verwendung dieses rekombinanten antigens in diagnostischen tests

Info

Publication number
ATE207120T1
ATE207120T1 AT93111883T AT93111883T ATE207120T1 AT E207120 T1 ATE207120 T1 AT E207120T1 AT 93111883 T AT93111883 T AT 93111883T AT 93111883 T AT93111883 T AT 93111883T AT E207120 T1 ATE207120 T1 AT E207120T1
Authority
AT
Austria
Prior art keywords
epstein
pcr
dna sequences
sequences encoding
envelope protein
Prior art date
Application number
AT93111883T
Other languages
English (en)
Inventor
Hans Prof Dr Wolf
Udo Dr Reischl
Manfred Dr Motz
Original Assignee
Hans Prof Dr Wolf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hans Prof Dr Wolf filed Critical Hans Prof Dr Wolf
Application granted granted Critical
Publication of ATE207120T1 publication Critical patent/ATE207120T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/705Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16211Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT93111883T 1993-07-23 1993-07-23 Dna-sequenzen des epstein-barr virus kodierend für ein diagnostisch relevantes virus-hüllprotein,durch pcr erhaltene expressionsklone und verwendung dieses rekombinanten antigens in diagnostischen tests ATE207120T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93111883A EP0726315B1 (de) 1993-07-23 1993-07-23 DNA-Sequenzen des Epstein-Barr Virus kodierend für ein diagnostisch relevantes Virus-Hüllprotein, durch PCR erhaltene Expressionsklone und Verwendung dieses rekombinanten Antigens in diagnostischen Tests

Publications (1)

Publication Number Publication Date
ATE207120T1 true ATE207120T1 (de) 2001-11-15

Family

ID=8213107

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93111883T ATE207120T1 (de) 1993-07-23 1993-07-23 Dna-sequenzen des epstein-barr virus kodierend für ein diagnostisch relevantes virus-hüllprotein,durch pcr erhaltene expressionsklone und verwendung dieses rekombinanten antigens in diagnostischen tests

Country Status (10)

Country Link
US (1) US5741656A (de)
EP (1) EP0726315B1 (de)
JP (1) JPH09502864A (de)
CN (1) CN1117150C (de)
AT (1) ATE207120T1 (de)
AU (1) AU7495494A (de)
CZ (1) CZ20996A3 (de)
DE (1) DE69330966T2 (de)
ES (1) ES2166757T3 (de)
WO (1) WO1995003415A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19526384C2 (de) * 1995-07-19 1997-07-10 Biotest Ag Rekombinante autologe Fusionsproteine des Epstein-Barr-Virus, sowie diese enthaltende Testkits zum Nachweis von Epstein-Barr-Virus-spezifischen Antikörpern
DE69940770D1 (de) 1998-03-04 2009-06-04 Biomerieux Bv Vervielfältigung und nachweis von ebv barf1 zur diagnose von nasopharyngealen karzinom
JP2009531464A (ja) 2006-03-29 2009-09-03 メリアル リミテッド 連鎖球菌に対するワクチン
CN104139155A (zh) * 2013-05-06 2014-11-12 福特汽车公司 用于生成模具组件的模的添加制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583564D1 (de) * 1984-08-23 1991-08-29 Hans Joachim Wolf Dna-sequenzen des ebv-genoms, rekombinante dna-molekuele, verfahren zur herstellung von ebv-verwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
WO1991002091A1 (en) * 1989-08-10 1991-02-21 Northwestern University Method of identifying herpesviruses and oligonucleotides for use therein
EP0585216A1 (de) * 1989-11-24 1994-03-09 The Council Of The Queensland Institue Of Medical Research Peptide gegen infektiöse mononukleose
PH31669A (en) * 1989-12-20 1999-01-18 Schering Corp Bcrf1 proteins as inhibitors of interferon-gamma.
DE69334191T2 (de) * 1992-03-13 2008-11-27 bioMérieux B.V. Epstein-Barr-Virus verwandte Peptide und Nukleinsäuresegmente

Also Published As

Publication number Publication date
WO1995003415A3 (en) 1995-03-16
DE69330966T2 (de) 2002-06-06
WO1995003415A2 (en) 1995-02-02
EP0726315B1 (de) 2001-10-17
JPH09502864A (ja) 1997-03-25
ES2166757T3 (es) 2002-05-01
CN1129460A (zh) 1996-08-21
CZ20996A3 (en) 1996-10-16
US5741656A (en) 1998-04-21
CN1117150C (zh) 2003-08-06
EP0726315A1 (de) 1996-08-14
AU7495494A (en) 1995-02-20
DE69330966D1 (de) 2001-11-22

Similar Documents

Publication Publication Date Title
AU2191597A (en) Vmp-like sequences of pathogenic borrelia
DE69432031D1 (de) Huntingtin-DNA, Protein und Verwendung
WO1997008314A3 (en) Telomere repeat binding factor and diagnostic and therapeutic use thereof
ATE338113T1 (de) Transferrin-rezeptor gene von haemophilus
DE3752131D1 (de) Impfstoffe und diagnosetest für haemophilus influenzae
WO1998011232A3 (en) Human nm23-like protein
ATE207120T1 (de) Dna-sequenzen des epstein-barr virus kodierend für ein diagnostisch relevantes virus-hüllprotein,durch pcr erhaltene expressionsklone und verwendung dieses rekombinanten antigens in diagnostischen tests
DE60026733D1 (de) Histone-deacetylase-8 proteine, nukleinsäuren und methoden zur verwendung
WO1996009391A3 (en) Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19
IL130164A0 (en) Mammalian chemokines
NZ242955A (en) Dna containing gene sequences corresponding to sequences causing alzheimers disease, detection, recombinant yeast with such code
DE3853693D1 (de) DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung.
WO2002088378A3 (en) 66784, a novel human potassium channel and uses therefor
EP2292762A3 (de) VMP-artige Sequenzen von krankheitserregenden Borrelienspezies und -stämmen
DE69633179D1 (de) Transferrinrezeptorgene
DE60138952D1 (de) 16836, ein mitglied der humanen phospholipase c familie und seine verwendungen
DE502004008729D1 (de) Gegen das Prothrombin-Fragment F1+2 gerichtete Antikörper, ihre Herstellung und Verwendung
ATE409746T1 (de) Neuer spannungsabhängiger kaliumkanal und seine verwendung zur entwicklung von therapeutika
ATE290549T1 (de) Ing2, ein mit iaps assoziiertes zellzyklusprotein,sowie zusammensetzungen, verfahren und verwendungen
WO2000007545A3 (en) Apoptosis proteins
DK1241179T3 (da) Humant protein med in vitro antiproliferativ aktivitet.
WO1999042586A3 (en) Exo1 and exo2, exocytotic proteins
ATE415422T1 (de) Menschliches gas-6 (growth arrest-specific gene 6) protein und dafür kodierende nukleinsäuren
ATE445714T1 (de) 15603, ein mitglied der humanen ionenkanal- familie
ATE380864T1 (de) Menschliches prostasin-ähnliches protein und dafür kodierende nukleinsäure

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification